Arrhythmias & EP
From the Journals
Underlying heart rhythm, not ICD shocks, drives mortality
Survival after implantable cardioverter-defibrillator shocks depends more on the nature of the underlying arrhythmic substrate than on any adverse...
Conference Coverage
FIDELIO-DKD: Finerenone cuts new-onset AFib in patients with type 2 diabetes and CKD
Conference Coverage
New STRENGTH analysis reignites debate on omega-3 CV benefits
The new analysis showing no benefits linked to higher achieved levels of EPA casts doubt over the use of high-dose omega-3 fatty acid products for...
Conference Coverage
Nasal spray resurrected after showing clinical benefits for PSVT
After missing its trial endpoint, etripamil, a treatment for paroxysmal supraventricular tachycardia, still appears beneficial.
Conference Coverage
LAAOS III: Surgical LAA closure cuts AFib stroke risk by one-third
The finding ‘opens a new paradigm’ for stroke prevention in atrial fibrillation and should change clinical guidelines, experts say.
News from the FDA/CDC
Cell phone, smart watch magnets can affect medical devices, FDA says
Conference Coverage
ACC 21 looks to repeat success despite pandemic headwinds
Plans for a hybrid meeting this year have pivoted again to fully virtual, but the focus on connection, education, and late-breaking science...
Latest News
Coffee intake may be driven by cardiovascular symptoms
Observational results show those with hypertension, angina, or arrhythmia drink less coffee than others, which may explain mixed results in...
News
FDA blazes path for ‘real-world’ evidence as proof of efficacy
FDA leaders must finalize guidance this year on submitting real-world observational evidence for regulatory decisions on drug and device efficacy...
Feature
A ‘mess’ of a diagnosis: Is it type 2 MI or a nonischemic imposter?
Often tough to tell apart and with surprisingly poor prognoses, type 2 MI and nonischemic myocardial injury lack trials to guide therapy. Whether...
Conference Coverage
Modest clinical gain for AF screening of asymptomatic elderly: STROKESTOP
Literally all known 75- and 76-year-olds in two Swedish regions were included, whether or not they were screened by mobile ECG recorder. But does...